Stoke Therapeutics, Inc. - Common Stock (STOK)
8.3300
+0.0700 (0.85%)
Stoke Therapeutics Inc is a biotechnology company focused on developing innovative therapies to treat genetic diseases by harnessing the power of messenger RNA (mRNA) biology
The company is dedicated to addressing the underlying causes of diseases by enhancing the production of proteins through its proprietary platform, which aims to restore the normal function of genes that are dysfunctional due to genetic mutations. By prioritizing precision medicine, Stoke Therapeutics works towards delivering transformative treatments that can improve the quality of life for patients suffering from various neurological disorders and other serious conditions.
Frequently Asked Questions
Is Stoke Therapeutics, Inc. - Common Stock publicly traded?
Yes, Stoke Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Stoke Therapeutics, Inc. - Common Stock trade on?
Stoke Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Stoke Therapeutics, Inc. - Common Stock?
The ticker symbol for Stoke Therapeutics, Inc. - Common Stock is STOK on the Nasdaq Stock Market
What is the current price of Stoke Therapeutics, Inc. - Common Stock?
The current price of Stoke Therapeutics, Inc. - Common Stock is 8.330
When was Stoke Therapeutics, Inc. - Common Stock last traded?
The last trade of Stoke Therapeutics, Inc. - Common Stock was at 4:00 pm EDT on March 20th, 2025
What is the market capitalization of Stoke Therapeutics, Inc. - Common Stock?
The market capitalization of Stoke Therapeutics, Inc. - Common Stock is 368.09M
How many shares of Stoke Therapeutics, Inc. - Common Stock are outstanding?
Stoke Therapeutics, Inc. - Common Stock has 44.19M shares outstanding.